Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Clinical trial NCT02687906 · COMPLETED
Trial details
- NCT number
- NCT02687906
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2026-07-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.